97 related articles for article (PubMed ID: 1238716)
1. [Study on cellular immunity and immunotherapy of malignant melanoma (author's transl)].
Ishihara K
Nihon Hifuka Gakkai Zasshi; 1975 Oct; 85(12):696-8. PubMed ID: 1238716
[No Abstract] [Full Text] [Related]
2. [The characterization of tumour-associated membrane-bound antigens and their implementation in the treatment of malignant melanoma (author's transl)].
Kokoschka EM
Wien Klin Wochenschr Suppl; 1979; 97():3-32. PubMed ID: 106559
[No Abstract] [Full Text] [Related]
3. [Local immunotherapy. Alternative therapy for malignant cutaneous lesions (demonstration on 30 patients with malignant melanoma) (author's transl)].
Kokoschka EM; Micksche M
Wien Klin Wochenschr; 1979 Mar; 91(5):150-4. PubMed ID: 425533
[TBL] [Abstract][Full Text] [Related]
4. [Immunotherapy of malignant melanoma (active specific and non-specific immune stimulation) (author's transl)].
Kokoschka EM; Micksche M
Wien Klin Wochenschr; 1976 Nov; 88(21):690-6. PubMed ID: 1007279
[TBL] [Abstract][Full Text] [Related]
5. Delayed cutaneous sensitivity reactions to extracts of autologous malignant melanoma: a second look.
Bluming AZ; Vogel CL; Ziegler JL; Kiryabwire JW
J Natl Cancer Inst; 1972 Jan; 48(1):17-24. PubMed ID: 4652371
[No Abstract] [Full Text] [Related]
6. [The treatment of advanced malignant melanoma with vaccina oncolysates (author's transl)].
Wallack MK
Nouv Presse Med; 1979 May; 8(23):1919-21. PubMed ID: 223123
[TBL] [Abstract][Full Text] [Related]
7. [Immunological reactions of skin melanoma patients to nonspecific and adaptive immunotherapy].
Trapeznikov NN; Iavorskiĭ VV; Kadagidze ZG; Malaev SG; Kupin VI
Vopr Onkol; 1977; 23(8):27-33. PubMed ID: 906404
[TBL] [Abstract][Full Text] [Related]
8. Immunotherapy of malignant melanoma with vaccinia virus.
Roenigk HH; Deodhar S; St Jacques R; Burdick K
Arch Dermatol; 1974 May; 109(5):668-73. PubMed ID: 4828533
[No Abstract] [Full Text] [Related]
9. [Studies on the immune status of melanoma patients: cell-mediated immune reactions in intracutaneous and epicutaneous tests in the lymphocyte transformation test and the leukocyte-migration inhibition test before and during BCG immunotherapy (author's transl)].
Knopf B; Wätzig V; Knöll B
Arch Geschwulstforsch; 1978; 48(8):722-8. PubMed ID: 753194
[TBL] [Abstract][Full Text] [Related]
10. Polyvalent melanoma cell vaccine induces delayed-type hypersensitivity and in vitro cellular immune response.
Barth A; Hoon DS; Foshag LJ; Nizze JA; Famatiga E; Okun E; Morton DL
Cancer Res; 1994 Jul; 54(13):3342-5. PubMed ID: 8012946
[TBL] [Abstract][Full Text] [Related]
11. Low doses of chemotherapy to inhibit suppressor T cells.
Berd D
Prog Clin Biol Res; 1989; 288():449-58. PubMed ID: 2566177
[No Abstract] [Full Text] [Related]
12. [Possibilities of an immunotherapy of malignant skin tumors with particular consideration of malignant melanomas (author's transl)].
Schöpf E
Ther Umsch; 1976 Aug; 33(8):538-42. PubMed ID: 1006610
[No Abstract] [Full Text] [Related]
13. Immunological mechanisms in choroidal melanoma.
Char DH
Trans Ophthalmol Soc U K (1962); 1977 Sep; 97(3):389-93. PubMed ID: 273995
[TBL] [Abstract][Full Text] [Related]
14. [Some immunological findings in malignant melanoma (author's transl)].
Richter J; Král V; Duchková H; Kubíková M
Cesk Dermatol; 1980 Feb; 55(1):12-8. PubMed ID: 6965892
[No Abstract] [Full Text] [Related]
15. [Cancer immunotherapy in dermatological view (author's transl)].
Lübbe D; Gstöttner R
Arch Geschwulstforsch; 1980; 50(2):182-5. PubMed ID: 7436703
[TBL] [Abstract][Full Text] [Related]
16. Induction of cell-mediated immunity to autologous melanoma cells and regression of metastases after treatment with a melanoma cell vaccine preceded by cyclophosphamide.
Berd D; Maguire HC; Mastrangelo MJ
Cancer Res; 1986 May; 46(5):2572-7. PubMed ID: 3697996
[TBL] [Abstract][Full Text] [Related]
17. [Development in the immunotherapy of malignant melanoma].
Tritsch H
Hautarzt; 1976 Jan; 27(1):1-7. PubMed ID: 767300
[TBL] [Abstract][Full Text] [Related]
18. Immunotherapy and immune competence of patients with malignant melanoma.
Kovarík J; Ninger E; Mechl Z; Zemanová D; Lauerová L; Sopková B; Svejda J; Bacovský B; Bártová A; Bártek J
Czech Med; 1983; 6(3):172-4. PubMed ID: 6416794
[No Abstract] [Full Text] [Related]
19. [Immunoreactivity in patients with surgically removed melanoma in the course of BCG vaccination (author's transl)].
Lochman I; Kyselá T; Machálek J; Lochmanová A; Beska F
Cesk Dermatol; 1980; 55(6):372-7. PubMed ID: 7460040
[No Abstract] [Full Text] [Related]
20. [Cellular immunity in patients with melanoma].
Gorodinova VV; Kholenshed A; Babakova SV
Vopr Onkol; 1976; 22(12):3-5. PubMed ID: 1020253
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
